CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $96,431
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Drutz David Director | Exercise or conversion | +20,000 | $2.60 | $52K | 49,785 |
| 2024-08-19 | Drutz David Director | Sale | −7,827 | $6.93 | $54K | 41,958 |
| 2024-08-19 | Drutz David Director | Exercise or conversion | +21,750 | $2.50 | $54K | 63,708 |
| 2024-08-19 | Drutz David Director | Sale | −8,184 | $6.88 | $56K | 55,524 |
| 2024-08-19 | Drutz David Director | Exercise or conversion · Stock Options (option to buy) | −20,000 | 0 | ||
| 2024-08-19 | Drutz David Director | Exercise or conversion · Stock Options (option to buy) | −21,750 | 4,350 | ||
| 2023-09-28 | Drutz David Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-08-15 | Drutz David Director | Purchase | +300 | $2.88 | $863 | 29,785 |
| 2023-03-23 | Drutz David Director | Purchase | +9,000 | $4.27 | $38K | 29,484 |
| 2022-11-18 | Drutz David Director | Exercise or conversion | +139 | $2.40 | $334 | 20,151 |
| 2022-11-18 | Drutz David Director | Exercise or conversion · Stock Options (option to buy) | −139 | 0 | ||
| 2022-09-29 | Drutz David Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-06-15 | Drutz David Director | Purchase | +1,000 | $8.00 | $8K | 20,012 |
| 2022-05-24 | Drutz David Director | Purchase | +1,200 | $4.50 | $5K | 19,012 |
| 2022-01-25 | Drutz David Director | Exercise or conversion | +70 | $2.40 | $168 | 17,882 |
| 2022-01-25 | Drutz David Director | Exercise or conversion · Stock Options (option to buy) | −70 | 69 | ||
| 2021-12-14 | Drutz David Director | Exercise or conversion | +139 | $2.40 | $334 | 17,812 |
| 2021-12-14 | Drutz David Director | Exercise or conversion · Stock Options (option to buy) | −139 | 0 | ||
| 2021-11-19 | Drutz David Director | Exercise or conversion | +70 | $2.40 | $168 | 17,673 |
| 2021-11-19 | Drutz David Director | Exercise or conversion · Stock Options (option to buy) | −70 | 0 |
Page 1 of 3 · 41 trades